Scientists discover critical factor in bone remodeling process

Bones are the living tissue on which the human skeleton is constructed and play a key role in enabling physical movements.

Hinge Bio’s $30M raise; Keros reports additional issues in Phase 2 PAH trial

Plus, news about Inflammasome Therapeutics, Johnson & Johnson and Verastem: Autoimmune disease startup nabs $30M: Hinge Bio Sign up to read this article for free.

January 16, 2025

MASCT by Hengrui Yuanzheng Biotechnology for Metastatic Colorectal Cancer: Likelihood of Approval

MASCT is under clinical development by Hengrui Yuanzheng Biotechnology and currently in Phase I for Metastatic Colorectal Cancer.

January 9, 2024

Fighting Rectal Cancer with AI: Researchers Secure $2.78M Grant

What You Should Know: – A glimmer of hope emerged today for rectal cancer patients as a collaborative effort between Case Western Reserve University (CWRU),

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.